Skip to content

Why Subscribe
About Us
Accreditation
Library
Live Events
Sign Up / Login

Why Subscribe
About Us
Accreditation
Library
Live Events
Sign Up / Login

Library

Speciality

Author / Speaker

Title of Presentation

Type of Media

Event

2024 Event

Clear

Displaying 451 - 475 of 2,711

«
1
…
17
18
19
20
21
…
109
»

Metastatic ER Positive Breast Cancer Updates in 2024

Metastatic ER Positive Breast Cancer Updates in 2024

By: Sayeh Lavasani, MD

Surgical management in breast cancer

Surgical management in breast cancer

By: Starr Mautner, MD

Post Neoadjuvant Chemotherapy and the Axilla

Post Neoadjuvant Chemotherapy and the Axilla

By: Terry Mamounas, MD

Denovo Metastatic Breast and the Role of Surgery

Denovo Metastatic Breast and the Role of Surgery

By: Terry Mamounas, MD

Neoadjuvant Updates

Neoadjuvant Updates

By: Tiﬀany Traina, MD

LCIS and ILC – Old Story with New Concerns

LCIS and ILC – Old Story with New Concerns

By: Timothy D’Alfonso, MD

HER-2 Disease: Amplification/Overexpression/Mutation in Breast Cancer

HER-2 Disease: Amplification/Overexpression/Mutation in Breast Cancer

By: Virginia Borges, MD

Metastatic Interrogations and Recommendations

Metastatic Interrogations and Recommendations

By: VK Gadi, MD, PhD

HER Family Transmembrane Proteins & BRCA | An Old Story Turns a New Corner

HER Family Transmembrane Proteins & BRCA | An Old Story Turns a New Corner

By: VK Gadi, MD, PhD

Immunotherapy: Wait, Why Wait

Immunotherapy: Wait, Why Wait

By: VK Gadi, MD, PhD

Transcatheter treatment in breast cancer

Transcatheter treatment in breast cancer

By: Wael Saad, MD

Ablation in Benign & Malignant Breast Disease

Ablation in Benign & Malignant Breast Disease

By: Yolanda Bryce, MD

Advances in the Treatment of CNS Malignancies

Advances in the Treatment of CNS Malignancies

By: Frances Chow, MD

Advances in the Treatment of CNS Malignancies

Advances in the Treatment of CNS Malignancies

By: Frances Chow, MD

Advances in the Treatment of CNS Malignancies

Advances in the Treatment of CNS Malignancies

By: Frances Elaine Chow, MD

Advances in the Treatment of CNS Malignancies

Advances in the Treatment of CNS Malignancies

By: Frances Elaine Chow, MD

Project Optimus and Optimizing Dose and Schedule in Early Phase Clinical Trials

Project Optimus and Optimizing Dose and Schedule in Early Phase Clinical Trials

By: Jan H. Beumer, PhD, PharmD, PhD, DABT

Project Optimus and Optimizing Dose and Schedule in Early Phase Clinical Trials

Project Optimus and Optimizing Dose and Schedule in Early Phase Clinical Trials

By: Jan H. Beumer, PhD, PharmD, PhD, DABT

Phase 1 Exp Cohorts vs Phase 2 Trials

Phase 1 Exp Cohorts vs Phase 2 Trials

By: Jeffrey Longmate, PHD

Statistical Considerations in Early Phase Clinical Trial Design in the Era of Targeted Therapy and Immunotherapy

Statistical Considerations in Early Phase Clinical Trial Design in the Era of Targeted Therapy and Immunotherapy

By: Mark Krailo, PhD

The Future of Developmental Therapeutics in Oncology

The Future of Developmental Therapeutics in Oncology

By: Patricia Mucci LoRusso, DO, PhD

The Future of Developmental Therapeutics in Oncology

The Future of Developmental Therapeutics in Oncology

By: Patricia Mucci LoRusso, DO, PhD

Novel Trial Designs for Early Phase Clinical Trials: Beyond 3+3

Novel Trial Designs for Early Phase Clinical Trials: Beyond 3+3

By: Paul Frankel, PhD

Novel Trial Designs for Early Phase Clinical Trials: Beyond 3+3

Novel Trial Designs for Early Phase Clinical Trials: Beyond 3+3

By: Paul Frankel, PhD

Translating Pre-Clinical Studies to NCI-CTEP Clinical Trials

Translating Pre-Clinical Studies to NCI-CTEP Clinical Trials

By: Steven D. Gore, MD

«
1
…
17
18
19
20
21
…
109
»

© 2024 MEC Inc. All rights reserved | Digital Marketing by Katapult Marketing

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok